FDA Advisory Panel Votes in Favor of Granting Emergency Use Authorization for Pfizer's COVID-19 Vaccine for Kids Aged 5-11

FDA Advisory Panel Votes in Favor of Granting Emergency Use Authorization for Pfizer's COVID-19 Vaccine for Kids Aged 5-11

HNGN

Published

The FDA advisory panel authorized Pfizer's COVID-19 vaccine for children aged 5 to 11, paving the way for vaccinations to start as early as next week.

Full Article